Disruptive Semiconductor Technology Leader Luxcore Signs Multi-year Colocation Deal with INAP
Luxcore selects INAP to support their ground breaking second generation LambdaRouterTM --- the first full wavelength optical router.
INAP chosen for its global presence in strategic markets, carrier neutrality and signature Performance IPTM service.
ATLANTA, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Internap Corporation (NASDAQ:INAP), ("INAP" or the "Company"), a provider of high-performance internet infrastructure including colocation, cloud and network services, and Luxcore, pioneers of a revolutionary all-optical wavelength routing platform, today announced a multi-year agreement for colocation services in seven global locations.
Luxcore, creator of the LambdaRouterTM - the world's first all-optical, wavelength switching, routing and transport system, selected INAP as its strategic partner to access the company's global coverage and connectivity to Tier 1 providers, utilizing INAP's access to dark fiber at all its locations. To demonstrate its disruptive technology during its initial rollout, Luxcore selected seven INAP data centers in the following major markets: Atlanta, Dallas, Silicon Valley (Santa Clara), New York & New Jersey Metro Area, Northern Virginia & D.C. Metro Area, Singapore and Amsterdam.
"Luxcore is poised to lead a significant shift in the underlying technology of the internet and we are excited to be their partner on that journey," said Corey Needles, INAP COLO's SVP and General Manager. "Given our global reach and network connectivity utilizing multiple carrier networks and our own fiber, we are uniquely positioned to help Luxcore succeed."
Luxcore is strategically partnering with INAP in a flagship venture to deliver the industry's first all-optical wavelength switching, routing and transport capabilities of the second generation LambdaRouterTM. When combined with INAP's global reach, unprecedented Tier 1 interconnectivity and dark fiber, Luxcore will introduce the "Optical Internet" providing significant new revenue opportunities for both INAP and Luxcore.
"When we introduced our first LambdaRouterTM in Spring of 2001, it was the world's first and only multi-terabit wavelength switching, routing and transport system based on proprietary optical semiconductor technology. The global telecom market subsequently collapsed and many said we were way ahead of our time. 15 years ago, there was no demand for such robust optical capacity. Fast forward to today's mobile, social and device-driven data economy and the need for ultra-high speed bandwidth is an absolute necessity. Global internet traffic has grown exponentially measured in zettabytes, and the underlying backbone infrastructure has hit a wall. Partnering with INAP allows Luxcore to fulfill its original corporate vision - to build the new 'Optical Internet,'" said Gerald Ramdeen, Luxcore Chairman and CEO.
With over 1 million square feet in 21 metropolitan markets and 89 POPs, INAP's collocation and network services offers the proximity and connectivity needed for INAP customers to be successful in the global marketplace.
Internap Corporation (NASDAQ: INAP) is a leading provider of internet infrastructure through both Colocation Business and Enterprise Services (including colocation, network connectivity, IP, bandwidth and managed hosting) and Cloud Services (including enterprise-grade AgileCLOUD, bare-metal servers and SMB iWeb platforms). INAP operates in Tier 3-type data centers in 21 metropolitan markets, primarily in North America, with 50 data centers and 89 POPs around the world. INAP operates a premium business model that provides high-power density colocation, low-latency bandwidth, and public and private cloud platforms in an expanding internet infrastructure industry. For more information, visit www.INAP.com
2001, Luxcore introduced the LambdaRouterTM - the world's first fully-integrated, all-optical switching, routing and transport system built upon proprietary semiconductor technology having origins from the Stanford University Center for Novel Optoelectronic Materials (CNOM), demonstrating 2.5Gbs and 10Gbs single port speeds at the lowest cost per bit. Luxcore Networks, Luxcore Optronics, Jedai Networks, (formerly Jedai Broadband Networks) - now Luxcore, Inc. has since leveraged in excess of $100MM in venture funding from prominent VC and private equity firms to develop the second generation of our award-winning LambdaRouterTM and the LambdaExchangeTM - introducing 100Gbs single port speeds at the lowest cost per bit. For more information, visit www.luxcore.com.
NAP Media Contacts
Richard Ramlall, VP IR & PR
Luxcore Media Contacts
Tamer Yacoub, VP Corporate Alliances
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Internap Corporation via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
SEMAFO Mourns Passing of Board Chairman Jean Lamarre23.11.2017 22:01 | Pressmeddelande
MONTREAL, Nov. 23, 2017 (GLOBE NEWSWIRE) -- SEMAFO (TSX:SMF) (OMX:SMF) announces with sadness the passing of Mr. Jean Lamarre, Chairman of the Board of Directors of the Corporation, on November 22, 2017 following a short illness. Mr. Lamarre joined the Corporation's Board of Directors in 1997 and was appointed Chairman of the Board in 2000, a position he held until his demise. "Jean made an indelible mark on SEMAFO, both in terms of his corporate governance expertise and his 45 years of experience in Africa," said President and CEO Benoit Desormeaux. "Over his 20-year tenure with SEMAFO, he brought unique insight, business acumen and leadership to the Corporation as it transitioned from an exploration company to a junior gold producer. He did this, always without compromising his values: the integrity of the Corporation, his deep love for Africa and its people, and his priority to SEMAFO's long-term sustainability. On behalf of SEMAFO's Board of Directors, management and employe
Premier to join industry leaders at BDA London forum23.11.2017 21:39 | Pressmeddelande
HAMILTON, Bermuda, Nov. 23, 2017 (GLOBE NEWSWIRE) -- Premier David Burt will join more than two-dozen Bermuda executives in a multi-industry forum being held in London next week to showcase the breadth of expertise and advantages offered by the island's global business market. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/78c5ac53-07f7-4dd8-83e0-753ea5b4c80b Organised by the Bermuda Business Development Agency (BDA), the one-day event Tuesday, November 28 at ME London has attracted over 200 registrants. It will feature top regulatory and industry leaders in moderated discussion panels covering re/insurance, captive insurance, insurance-linked securities, asset management, family offices, and trust and private-client business. A networking reception will wrap the event in the evening. "The government supports the Bermuda Business Development Agency in this awareness-raising event that offers such gre
Crown Bioscience and Data Sciences International (DSI) Partner to Advance Metabolic Disease Research Using an Implanted Telemetry Device for Long-Term Blood Glucose Monitoring23.11.2017 14:00 | Pressmeddelande
SANTA CLARA, Calif., Nov. 23, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation cardiovascular and metabolic disease research, announces the successful development of an enhanced method for preclinical obesity and type 2 diabetes studies in partnership with Data Sciences International (DSI). Crown Bioscience's clinically relevant models and DSI's HD-XG implantable glucose device combine to create a superior approach to preclinical metabolic disease research. Recently published work in the Journal of Endocrinological Investigation and Nature's Scientific Reports demonstrates the advantages of a new method using DSI's HD-XG implantable glucose device and Crown Bioscience's models of spontaneous and diet-induced diabetes. The HD-XG device allows for continuous, long-term measurement
LeoVegas AB: Valberedning utsedd i LeoVegas inför årsstämma 201823.11.2017 11:50 | Pressmeddelande
Enligt de principer för valberedning i LeoVegas AB (publ) ("Bolaget" eller "LeoVegas") som antogs på årsstämman den 17 maj 2017 ska valberedningen bestå av fyra ledamöter utsedda av de tre största aktieägarna per den 30 september 2017, jämte styrelsens ordförande. Baserat på ovanstående har valberedningen inför årsstämman 2018 fastställts till att bestå av följande personer som tillsammans representerar cirka 23 procent av antalet aktier och röster i Bolaget per den 30 september 2017: Anders Fast, valberedningens ordförande och utsedd av Gustaf Hagman Joachim Spetz, utsedd av Swedbank Robur Fonder Dan-Alp Lindberg utsedd Robin Ramm-Ericson Mårten Forste, styrelseordförande Valberedningens förslag kommer att presenteras i kallelsen till årsstämman 2018 samt på bolagets hemsida, www.leovegasgroup.com.
LeoVegas AB: Nomination committed appointed for LeoVegas ahead of 2018 Annual General Meeting23.11.2017 11:50 | Pressmeddelande
In accordance with the principles for appointment of a nomination committee of LeoVegas AB (publ) ("the Company" or "LeoVegas") that were adopted by the Annual General Meeting on 17 May 2017, the Nomination Committee shall consist of four members appointed by the three largest shareholders as at 30 September 2017, together with the Chairman of the Board. Based on the above, the Nomination Committee ahead of the 2018 Annual General Meeting has been determined to consist of the following persons, who represent approximately 23% of the number of shares and votes in the Company as per 30 September 2017: Anders Fast, Nomination Committee chair, representing Gustaf Hagman Joachim Spetz, representing Swedbank Robur Fonder Dan-Alp Lindberg, representing Robin Ramm-Ericson Mårten Forste, Chairman of the Board The No
Hemcheck Sweden AB: Viktigt patent beviljat av PRV23.11.2017 09:00 | Pressmeddelande
PRESSMEDDELANDE Viktigt patent beviljas av PRV PRV, det svenska patent och registreringsverket, meddelar att HemChecks patentansökan gällande bolagets blodseparationsteknik kommer att beviljas för Sverige den 19 december 2017. Patentets publiceringsnummer kommer att bli 539853. -För HemCheck är patentet strategiskt mycket viktigt, eftersom det innefattar vår teknik för blodseparation. Det skyddar den teknik som gör att en ej definierad blodvolym kan användas i vårt engångstest och det är just det som gör vårt hemolystest så unikt, enkelt och användarvänligt - och dessutom mycket snabbt. I kombination med övriga patent har vi nu ett mycket bra skydd för den metod som HemChecks affärsidé i grunden bygger på, säger vd Annelie Brolinson i en kommentar. En internationell patentansökan har lämnats in för att söka skydd på övriga viktiga marknader. För ytterligare information, kontakta: Hemcheck Sweden AB
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum